Description: Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers Drewson, an anti-tumor biotherapeutic drug for the treatment of renal cancer, malignant melanoma, and cancerous thoracic and peritoneal effusion; and Xinde Lusheng for the treatment of kidney cancer, melanoma, lung cancer, gastric cancer, malignant lymphoma, breast cancer, ovarian tumor, bowel cancer, bladder cancer, head and neck tumor, leukemia and cancerous pleural effusion, etc. The company also provides Xin grain health, a recombinant human granulocyte colony stimulating factor injection; and Tourbo, a recombinant human erythropoietin injection for the treatment of anemia caused by renal insufficiency, including dialysis and non-dialysis patients. Jiangsu Sihuan Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Jiangyin, China.
Home Page: www.000518shsw.com/shsw
No. 7 Binjiang East Road
Jiangyin,
214400
China
Phone:
86 510 8640 8558
Officers
| Name | Title |
|---|---|
| Mr. Yu Guo | GM & Chairman |
| Ms. Haizhen Xu | CFO & Head of Accounting |
| Mr. Yang Zhou | Sec. of the Board & Deputy GM |
Exchange: SHE
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 6.4587 |
| Price-to-Sales TTM: | 11.7709 |
| IPO Date: | 1993-04-26 |
| Fiscal Year End: | December |
| Full Time Employees: | 254 |